| Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality SM Domchek, TM Friebel, CF Singer, DG Evans, HT Lynch, C Isaacs, ... Jama 304 (9), 967-975, 2010 | 1770 | 2010 |
| Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group TR Rebbeck, T Friebel, HT Lynch, SL Neuhausen, L Van’t Veer, ... Journal of clinical oncology 22 (6), 1055-1062, 2004 | 1563 | 2004 |
| Risk-reducing salpingo-oophorectomy for the prevention of BRCA1-and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study ND Kauff, SM Domchek, TM Friebel, ME Robson, J Lee, JE Garber, ... Journal of clinical oncology 26 (8), 1331-1337, 2008 | 724 | 2008 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 588 | 2015 |
| Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation … TR Rebbeck, T Friebel, T Wagner, HT Lynch, JE Garber, MB Daly, ... Journal of clinical oncology 23 (31), 7804-7810, 2005 | 528 | 2005 |
| Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017 | 463 | 2017 |
| Characterization of BRCA1 and BRCA2 Mutations in a Large United States Sample S Chen, ES Iversen, T Friebel, D Finkelstein, BL Weber, A Eisen, ... Journal of Clinical Oncology 24 (6), 863-871, 2006 | 433 | 2006 |
| Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study SM Domchek, TM Friebel, SL Neuhausen, T Wagner, G Evans, C Isaacs, ... The lancet oncology 7 (3), 223-229, 2006 | 405 | 2006 |
| Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ... PLoS genetics 9 (3), e1003212, 2013 | 348 | 2013 |
| Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations TR Rebbeck, TM Friebel, E Friedman, U Hamann, D Huo, A Kwong, ... Human mutation 39 (5), 593-620, 2018 | 339 | 2018 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 324 | 2015 |
| Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: a systematic review and meta-analysis TM Friebel, SM Domchek, TR Rebbeck Journal of the National Cancer Institute 106 (6), dju091, 2014 | 313 | 2014 |
| Uterine cancer after risk-reducing salpingo-oophorectomy without hysterectomy in women with BRCA mutations CA Shu, MC Pike, AR Jotwani, TM Friebel, RA Soslow, DA Levine, ... JAMA oncology 2 (11), 1434-1440, 2016 | 268 | 2016 |
| Validity of Models for Predicting BRCA1 and BRCA2 Mutations G Parmigiani, S Chen, ES Iversen Jr, TM Friebel, DM Finkelstein, ... Annals of internal medicine 147 (7), 441-450, 2007 | 168 | 2007 |
| CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer C Zeigler-Johnson, T Friebel, AH Walker, Y Wang, E Spangler, ... Cancer research 64 (22), 8461-8467, 2004 | 153 | 2004 |
| Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer FJ Couch, KB Kuchenbaecker, K Michailidou, GA Mendoza-Fandino, ... Nature communications 7 (1), 11375, 2016 | 137 | 2016 |
| Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers TM Friebel, SM Domchek, SL Neuhausen, T Wagner, DG Evans, C Isaacs, ... Clinical breast cancer 7 (11), 875-882, 2007 | 108 | 2007 |
| Relationship of established risk factors with breast cancer subtypes AM McCarthy, T Friebel‐Klingner, S Ehsan, W He, M Welch, J Chen, ... Cancer medicine 10 (18), 6456-6467, 2021 | 102 | 2021 |
| Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers SM Domchek, TM Friebel, JE Garber, C Isaacs, E Matloff, R Eeles, ... Breast cancer research and treatment 124, 195-203, 2010 | 84 | 2010 |
| Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers X Chai, TM Friebel, CF Singer, DG Evans, HT Lynch, C Isaacs, JE Garber, ... Breast cancer research and treatment 148, 397-406, 2014 | 75 | 2014 |